Ivan C Nordin is a notable inventor based in Holland, MI (US), recognized for his significant contributions to the field of pharmaceuticals. He holds a total of 7 patents, showcasing his dedication to innovation and research in anticonvulsant medications.

Latest Patents

Nordin's latest patents include N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and N-(2,6-Disubstitutedphenyl)-N'-3- and 4-pyridinyl ureas. These compounds, along with their pharmaceutically acceptable acid addition salts, exhibit anticonvulsant activity. His work also details a process for their manufacture, formulations containing these compounds, and a method for treating epilepsy using these compounds in unit dosage form.

Career Highlights

Throughout his career, Nordin has worked with prominent companies such as Warner-Lambert Company and Parke-Davis Company. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Some of his notable coworkers include Dietrich Schweiss and Sandra J Lobbestael, who have collaborated with him on various projects throughout his career.

Conclusion

Ivan C Nordin's contributions to the field of pharmaceuticals, particularly in the development of anticonvulsant medications, highlight his innovative spirit and commitment to improving healthcare. His patents and collaborations reflect a career dedicated to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com